Sagimet Bioscience a Aktie
WKN DE: A3CPAM / ISIN: US7867001049
|
13.08.2025 13:39:20
|
Sagimet Biosciences Inc Q2 Loss Increases, But Beats Estimates
(RTTNews) - Sagimet Biosciences Inc (SGMT) reported Loss for its second quarter that increased from the same period last year but beat the Street estimates.
The company's earnings totaled -$10.386 million, or -$0.32 per share. This compares with -$8.118 million, or -$0.25 per share, last year.
Analysts on average had expected the company to earn -$0.5 per share. Analysts' estimates typically exclude special items.
Sagimet Biosciences Inc earnings at a glance (GAAP) :
-Earnings: -$10.386 Mln. vs. -$8.118 Mln. last year. -EPS: -$0.32 vs. -$0.25 last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sagimet Biosciences Inc Registered Shs -A-mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Sagimet Biosciences Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
| Sagimet Biosciences Inc Registered Shs -A- | 6,25 | -1,57% |
|